囊性纤维化病的未来:一个全球视角
Felix Ratjen1,2,3
1Department of Pediatrics, Division of Respiratory Medicine, Ontario, Canada.
Pediatric pulmonology
|October 17, 2024
概括
患有特定突变的囊性纤维化 (CF) 患者通过CF跨膜调节器 (CFTR) 调节器显示出改善的结果. 扩大全球获取这些改变生活的CFTR调节器疗法对于所有符合条件的儿童至关重要.
科学领域:
- 医学研究 医学研究
- 肺部病理学 肺部病理学
- 遗传学 是一个遗传学.
背景情况:
- 囊性纤维化 (CF) 是一种影响多个器官,主要是肺部的遗传性疾病.
- 在CF治疗中,CF跨膜调节器 (CFTR) 调节器出现了显著的进步.
- 这些调节器对具有特定CFTR基因突变的患者非常有效.
研究的目的:
- 审查CFTR调节器对CF疾病管理的影响.
- 根据新疗法,讨论CF护理模式的不断变化.
- 倡导全球更广泛地获得CFTR调节器疗法.
主要方法:
- 对CFTR调节器和CF护理研究的文献综述.
- 分析当前的治疗准则和获取差异.
- 关于未来CF护理范式的专家意见综合.
主要成果:
- 在符合条件的CF患者中,CFTR调节器已经显示出肺部疾病严重程度和其他表现的显著改善.
- 获得这些变革性疗法的机会分布不公平,主要局限于高收入国家.
- 关于其他CF药物的持续需要以及对调节器患者的密集监测仍然存在问题.
结论:
- CFTR调节器代表了囊性纤维化治疗中的范式转变.
- 公平的全球获取CFTR调节器是一个关键的未满足的需求.
- 未来的CF护理模式必须适应整合这些疗法并解决正在进行的研究问题.
相关概念视频
Cystic Fibrosis: Management
144
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
144
Cystic Fibrosis: Pathogenesis
194
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
194
Microorganisms in Medicine and Therapeutics
2
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
2
COPD: Pathogenesis and Clinical Features
239
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
239
Chronic Obstructive Pulmonary Disease-I: Introduction
2.8K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.8K


